TY - JOUR
T1 - The effects of recptor modulators on the AHH induction activity of 2,3,7,8-TCDD in C57BL/6 and DBA/2 mice
AU - Bannister, R.
AU - Kelley, M.
AU - Safe, S.
N1 - Funding Information:
This research was supported by the National Institutes of Health, ESO3843, and the Texas Agricultural Experiment Station.
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1987
Y1 - 1987
N2 - Treatment of immature male C57BL/6J mice with 2,2′,4,4′,5,5′-hexachlorobiphenyl (HCB, 100-1000 umol/kg) resulted in a 44-200% increase in levels of the 2,3,7,8-TCDD hepatic cytosolic receptor protein for up to 14 days. The increased binding was not due to an alteration of the affinity of 2,3,7,8-TCDD for the receptor as shown by Scatchard analysis. In contrast treatment of immature DBA/2 mice with 2,2′,4,4′,5,5′-HCB did not result in increased hepatic cytosolic receptor levels which were non-detectable in the treated and untreated animals. C57BL/6 mice were pretreated with 2,2′,4,4′,5,5′-HCB (500 umol/kg) and after 7 days 2,3,7,8-TCDD (0.32 ug/kg) was administered by i.p. injection; 14 days later the hepatic microsomal aryl hydrocarbon hydroxylase (AHH) and ethoxyresorufin O-deethylase (EROD) activities were 587 and 1383 pmol product/mg protein/min respectively. In contrast, these activities were 340 and 437 pmol/mg protein/min in animals treated with only 2,3,7,8-TCDD. These synergistic effects were only seen in mice treated with submaximal enzymeinducing doses of 2,3,7,8-TCDD. Treatment of DBA/2 mice with 2,2′,4,4′,5,5′-HCB (500 umol/kg) and varying dose levels of 2,3,7,8-TCDD (10-5000 nmol/kg) resulted in apparent synergistic AHH and EROD induction activities in mice treated with submaximal and maximal enzyme inducing doses of 2,3,7,8-TCDD.
AB - Treatment of immature male C57BL/6J mice with 2,2′,4,4′,5,5′-hexachlorobiphenyl (HCB, 100-1000 umol/kg) resulted in a 44-200% increase in levels of the 2,3,7,8-TCDD hepatic cytosolic receptor protein for up to 14 days. The increased binding was not due to an alteration of the affinity of 2,3,7,8-TCDD for the receptor as shown by Scatchard analysis. In contrast treatment of immature DBA/2 mice with 2,2′,4,4′,5,5′-HCB did not result in increased hepatic cytosolic receptor levels which were non-detectable in the treated and untreated animals. C57BL/6 mice were pretreated with 2,2′,4,4′,5,5′-HCB (500 umol/kg) and after 7 days 2,3,7,8-TCDD (0.32 ug/kg) was administered by i.p. injection; 14 days later the hepatic microsomal aryl hydrocarbon hydroxylase (AHH) and ethoxyresorufin O-deethylase (EROD) activities were 587 and 1383 pmol product/mg protein/min respectively. In contrast, these activities were 340 and 437 pmol/mg protein/min in animals treated with only 2,3,7,8-TCDD. These synergistic effects were only seen in mice treated with submaximal enzymeinducing doses of 2,3,7,8-TCDD. Treatment of DBA/2 mice with 2,2′,4,4′,5,5′-HCB (500 umol/kg) and varying dose levels of 2,3,7,8-TCDD (10-5000 nmol/kg) resulted in apparent synergistic AHH and EROD induction activities in mice treated with submaximal and maximal enzyme inducing doses of 2,3,7,8-TCDD.
UR - http://www.scopus.com/inward/record.url?scp=0023595044&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023595044&partnerID=8YFLogxK
U2 - 10.1016/0045-6535(87)90150-0
DO - 10.1016/0045-6535(87)90150-0
M3 - Article
AN - SCOPUS:0023595044
SN - 0045-6535
VL - 16
SP - 1687
EP - 1689
JO - Chemosphere
JF - Chemosphere
IS - 8-9
ER -